ID   TCPH-MM04
AC   CVCL_M192
SY   MM4; MM05
DR   Wikidata; Q54906034
RX   PubMed=23516439;
RX   PubMed=31038674;
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=31038674).
CC   Transformant: ChEBI; CHEBI_46661; Asbestos.
CC   Omics: Genome sequenced.
CC   Derived from site: In situ; Lung, pleura; UBERON=UBERON_0000977.
DI   NCIt; C45665; Pleural biphasic mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 19-12-24; Version: 13
//
RX   PubMed=23516439; DOI=10.1371/journal.pone.0058132; PMCID=PMC3597627;
RA   Relan V., Morrison L.E., Parsonson K., Clarke B.E., Duhig E.E.,
RA   Windsor M.N., Matar K.S., Naidoo R., Passmore L., McCaul E.,
RA   Courtney D., Yang I.A., Fong K.M., Bowman R.V.;
RT   "Phenotypes and karyotypes of human malignant mesothelioma cell
RT   lines.";
RL   PLoS ONE 8:E58132-E58132(2013).
//
RX   PubMed=31038674; DOI=10.1093/carcin/bgz066;
RA   Oey H., Daniels M., Relan V., Chee T.M., Davidson M.R., Yang I.A.,
RA   Ellis J.J., Fong K.M., Krause L., Bowman R.V.;
RT   "Whole-genome sequencing of human malignant mesothelioma tumours and
RT   cell lines.";
RL   Carcinogenesis 40:724-734(2019).
//